Ardelyx (ARDX) EBITDA Margin Growth (1y) (2014 - 2026)
Ardelyx (ARDX) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 1,433.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,433.00 |
| Dec 31, 2025 | -292.00 |
| Sep 30, 2025 | 13,502.00 |
| Jun 30, 2025 | 388.00 |
| Mar 31, 2025 | 458.00 |
| Dec 31, 2024 | 8,844.00 |
| Sep 30, 2024 | -1,085.00 |
| Jun 30, 2024 | 5,582.00 |
| Mar 31, 2024 | 17,563.00 |
| Dec 31, 2023 | -10,893.00 |
| Sep 30, 2023 | 45,195.00 |
| Jun 30, 2023 | 96,337.00 |
| Mar 31, 2023 | 571,241.00 |
| Dec 31, 2022 | 345,538.00 |
| Sep 30, 2022 | 316,185.00 |
| Jun 30, 2022 | 237,666.00 |
| Mar 31, 2022 | -545,542.00 |
| Dec 31, 2021 | -189,981.00 |
| Sep 30, 2021 | -296,814.00 |
| Jun 30, 2021 | -209,601.00 |